پديد آورندگان :
Mahjoub Soleiman نويسنده , TAMADOONI AHMAD نويسنده , ZANJANCHI NIKOO MASEOUD نويسنده , MOGHADMNIA ALI AKBAR نويسنده
چكيده لاتين :
BACKGROUND: Thalassemia is the most common hereditary disease in the world. Thalassemic erythrocytes are exposed
to higher oxidative stress and lipid peroxidation. The aim of this study was to investigate the effects of beta-carotene
and vitamin E on erythrocytes lipid peroxidation in beta-thalassemia patients.
METHODS: A prospective double-blind, placebo-controlled study of the effect of beta-carotene and vitamin E on lipid
peroxidation in erythrocytes membranes was performed on 120 beta-thalassemia major patients in four groups. The
patients were supplemented for 4 weeks as follows: group I with beta-carotene (13 mg/day), group 2 with vitamin E
(550 mg/day), group 3 with beta-carotene plus vitamin E and group 4 with placebo. We prepared all capsules for 4
groups in the same shape and color. Measurements of serum beta-carotene and vitamin E were performed by high performance
liquid chromatography. After preparation of ghost cells from blood specimens, malondialdehyde (MDA) was
determined as index oflipid peroxidation in erythrocytes membranes before and after treatment.
RESULTS: The levels of serum beta-carotene and vitamin E were significantly lower and MDA concentrations in erythrocytes
membranes were significantly higher in beta-thalassemia patients compared to controls (P(LESS THAN)O.OOI). In groups
that treated with vitamin supplements for 4-weeks, lipid peroxidation rates were significantly reduced after treatment
(P(LESS THAN)O.OOI), but in placebo group there was not significant difference (P(GREATER THAN_0.05).
CONCLUSIONS: Our findings provide evidence that an oral treatment with beta-carotene and vitamin E can significantly
reduce lipid peroxidation of erythrocytes membranes and could be useful in management of beta-thalassemia major
patients